Regenerative Zellen in der ästhetischen und rekonstruktiven Medizin

Abstract

Disclaimer: This document is a summary for public release of a scientific recommendation on classification of advanced therapy medicinal products. The original text adopted by the Committee for Advanced Therapies (CAT) has been redacted to delete commercially confidential information. The present scientific recommendation refers exclusively to the case as presented to the European Medicines Agency (EMA) without prejudice to future evaluations by the Agency. This scientific recommendation is not binding and is without prejudice to any decision taken by Member State competent authorities on matters falling within their own remits. Short descriptor (or name when available) of the proposed active substance The active substance is a recombinant Herpes Simplex Virus type 1 (HSV-1) containing the gene encoding human granulocyte macrophage colony-stimulating factor (GM-CSF)